Suchergebnisse - "Gulick, Roy M"

PubPharm (263)

61

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

enthalten in: Nature medicine | 2017

von Caskey, M. | Schoofs, T. | Gruell, H. | +34

62

Invasive Aspergillus Sinusitis in Human Immunodeficiency Virus Infection : Case Report and Review of the Literature

enthalten in: Open forum infectious diseases | 2016

von Humphrey, J. | Walsh, T. | Gulick, R.

63

Corrigendum : Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

enthalten in: Nature | 2016

von Caskey, M. | Klein, F. | Lorenzi, J. | +22

ErratumFor: Nature. 2015 Jun 25;522(7557):487-91. - PMID 25855300

64

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

enthalten in: Nature | 2016

von Scheid, J. | Horwitz, J. | Bar-On, Y. | +30

65

The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2016

von Girouard, M. | Sax, P. | Parker, R. | +6

CommentIn: Clin Infect Dis. 2016 Mar 15;62(6):792-4. - PMID 26658055

66

Cost-Effectiveness of Meningococcal Vaccination Among Men Who Have Sex With Men in New York City

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2016

von Simon, M. | Weiss, D. | Geevarughese, A. | +6

67

The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States

enthalten in: Clinical infectious diseases | 2016

von Girouard, M. | Sax, P. | Parker, R. | +6

68

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

enthalten in: Nature | 2016

von Scheid, J. | Horwitz, J. | Bar-On, Y. | +30

69

Corrigendum: Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

enthalten in: Nature | 2016

von Caskey, M. | Klein, F. | Lorenzi, J. | +22

70

PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305)

enthalten in: The journal of infectious diseases | 2016

von Gulick, R. | Wilkin, T. | Chen, Y. | +26